Botanical species · safety record

Anacyclus pyrethrum

The EFSA Compendium of Botanicals holds 3 constituent measurements and 1 adverse-effect record for Anacyclus pyrethrum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anacyclus pyrethrum (L.) Lag.

3Constituent measurements
1Safety records
3Cited sources
20Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 20 licensed products naming Anacyclus pyrethrum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Flower
  • Root
  • Root extract

What the records describe

Constituents measured

  • Eugenol1
  • Lignans1
  • Tyramine1

Plant parts

  • Roots and other underground parts2

Preparations

  • Solvent extraction2

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
EugenolRoots and other underground partsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
LignansNo resolvable identifier
TyramineNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Not statedDigestiveRoots and other underground partsSolvent extractionOtherResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Burden, R. S., Crombie, Leslie. Amides of vegetable origin. XII. New series of 2,4-alka dienoic tyramine amides from Anacyclus pyrethrum. Journal of the chemical society [section] c: organic, 1969, vol. (18), p. 2477-81.
  2. Tewfik, S. Working protocol for isolation and identification of bioactive compounds from aqueous extract of medicinal plants. World review of science, technology and sustainable development, 2007, vol. 4, no. 1, p. 86-97. DOI
  3. Zaidi, Syed Mohd. Abbas., Pathan, Shadab Ahmad., Singh, Surender., Jamil, Shakir., Ahmad, Farhan Jalees., Khar, Roop Krishen. Anticonvulsant, anxiolytic and neurotoxicity profile of Aqarqarha (Anacyclus pyrethrum) DC (Compositae) root ethanolic extract. Pharmacology & pharmacy, 2013, vol. 4, no. 7), 535-54, p. 7 pp.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue